Jonathan E. Dowell
Chief of the Section of Hematology and Oncology · Dallas Veterans Affairs Medical Center
Credentials: · ·
History
Present- Present
Section of Hematology and Oncology Division · Dallas Veterans Affairs Medical Center
- Present
Hematology and Oncology · UT Southwestern
- 1997–2000
- 1994–1996
- 1993–1994
- 1989–1993
University of Chicago Pritzker School of Medicine
Research
Non-Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network · 2022 · 1,255 citations
Non-Small Cell Lung Cancer, Version 4.2024, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network · 2024 · 922 citations
JAMA Oncology · 2018 · 906 citations
28 papers
13 papers
12 papers
11 papers
11 papers
10 papers · 2 as a fellow
10 papers
10 papers
Clinical trials
- 2011–2016
Dose Escalation Trial of Nitroglycerin, 5-flourouracil and Rad Therapy for Rectal Cancer
Principal investigator · Completed · Phase 1
University of Texas Southwestern Medical Center
- 2006–2010
Cisplatin, Pemetrexed and Bevacizumab for Untreated Malignant Mesothelioma
Principal investigator · Completed · Phase 2
University of Texas Southwestern Medical Center
- 2025–2031
Site PI · Recruiting · Phase 3
Canadian Cancer Trials Group
- 2023–2027
A Study of LP-300 With Carboplatin and Pemetrexed in Never Smokers With Advanced Lung Adenocarcinoma
Site PI · Recruiting · Phase 2
Lantern Pharma Inc.